Amplitude Surgical SA

ENXTPA:AMPLI Stock Report

Market Cap: €153.5m

Amplitude Surgical Management

Management criteria checks 3/4

Amplitude Surgical's CEO is Olivier Jallabert, appointed in Jan 1997, has a tenure of 9.58 years. total yearly compensation is €530.06K, comprised of 65.6% salary and 34.4% bonuses, including company stock and options. directly owns 0.26% of the company’s shares, worth €392.64K. The average tenure of the management team and the board of directors is 6.3 years and 4.2 years respectively.

Key information

Olivier Jallabert

Chief executive officer

€530.1k

Total compensation

CEO salary percentage65.6%
CEO tenure28yrs
CEO ownership0.3%
Management average tenure6.3yrs
Board average tenure4.2yrs

Recent management updates

Here's Why Shareholders Will Not Be Complaining About Amplitude Surgical SA's (EPA:AMPLI) CEO Pay Packet

Dec 12
Here's Why Shareholders Will Not Be Complaining About Amplitude Surgical SA's (EPA:AMPLI) CEO Pay Packet

Recent updates

Here's Why Shareholders Will Not Be Complaining About Amplitude Surgical SA's (EPA:AMPLI) CEO Pay Packet

Dec 12
Here's Why Shareholders Will Not Be Complaining About Amplitude Surgical SA's (EPA:AMPLI) CEO Pay Packet

Amplitude Surgical SA's (EPA:AMPLI) Popularity With Investors Is Clear

Sep 19
Amplitude Surgical SA's (EPA:AMPLI) Popularity With Investors Is Clear

Investors Will Want Amplitude Surgical's (EPA:AMPLI) Growth In ROCE To Persist

May 22
Investors Will Want Amplitude Surgical's (EPA:AMPLI) Growth In ROCE To Persist

CEO Compensation Analysis

How has Olivier Jallabert's remuneration changed compared to Amplitude Surgical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024€530k€348k

€2m

Mar 31 2024n/an/a

-€727k

Dec 31 2023n/an/a

-€3m

Sep 30 2023n/an/a

-€5m

Jun 30 2023€617k€345k

-€6m

Mar 31 2023n/an/a

-€5m

Dec 31 2022n/an/a

-€4m

Sep 30 2022n/an/a

-€3m

Jun 30 2022€693k€345k

-€2m

Dec 31 2021n/an/a

-€10m

Sep 30 2021n/an/a

-€12m

Jun 30 2021€654k€338k

-€13m

Mar 31 2021n/an/a

-€19m

Dec 31 2020n/an/a

-€24m

Sep 30 2020n/an/a

-€19m

Jun 30 2020€411k€323k

-€14m

Mar 31 2020n/an/a

-€5m

Dec 31 2019n/an/a

€4m

Sep 30 2019n/an/a

-€3m

Jun 30 2019€2m€300k

-€9m

Mar 31 2019n/an/a

-€9m

Dec 31 2018n/an/a

-€8m

Sep 30 2018n/an/a

-€9m

Jun 30 2018€546k€295k

-€9m

Compensation vs Market: Olivier's total compensation ($USD546.68K) is above average for companies of similar size in the French market ($USD414.64K).

Compensation vs Earnings: Olivier's compensation has been consistent with company performance over the past year.

CEO

Olivier Jallabert (56 yo)

28yrs

Tenure

€530,063

Compensation

Mr. Olivier Jallabert is a Founder of Amplitude Surgical SA and has been its Chief Executive Officer since June 10, 2015. Mr. Jallabert is a Founder, Chief Executive Officer and Chairman of Management Boar...

Leadership Team

NamePositionTenureCompensationOwnership
Olivier Jallabert
Founder28yrs€530.06k0.26%
€ 392.6k
Dimitri Borchtch
CFO & Vice-President of Financeno datano datano data
Muriel Marmilloud
Director of Operations6.3yrsno datano data
Bruno Jugnet
Vice President of International Marketing & Sales - France6yrsno datano data

6.3yrs

Average Tenure

Experienced Management: AMPLI's management team is seasoned and experienced (6.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Olivier Jallabert
Founder9.6yrs€530.06k0.26%
€ 392.6k
Daniel Caille
Independent Director9.6yrsno data0.000020%
€ 30.7
Sophie Lombard
Independent Directorless than a yearno datano data
Stefano Drago
Chairman of the Board4.2yrsno data0%
€ 0
Augustin Grandcolas
Censor4.1yrsno datano data
Charlotte Pennec
Director4.2yrsno data0%
€ 0
Mateo Paniker
Censor4.1yrsno datano data

4.2yrs

Average Tenure

52yo

Average Age

Experienced Board: AMPLI's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 22:29
End of Day Share Price 2025/01/08 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Amplitude Surgical SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lionel LabourdetteKepler Cheuvreux
Stephane SumarNatixis S.A.
Christophe-Raphael GanetODDO BHF Corporate & Markets